Abstract
Capsid-targeted viral inactivation is an antiviral strategy in which toxic fusion proteins are targeted to virions, where they inhibit viral multiplication by destroying viral components. These fusion proteins consist of a virion structural protein moiety and an enzymatic moiety such as a nuclease. Such fusion proteins can severely inhibit transposition of yeast retrotransposon Ty1, an element whose transposition mechanistically resembles retroviral multiplication. We demonstrate that expression of a murine retrovirus capsid-staphylococcal nuclease fusion protein inhibits multiplication of the corresponding murine leukemia virus by 30- to 100-fold. Staphylococcal nuclease is apparently inactive intracellularly and hence nontoxic to the host cell, but it is active extracellularly because of its requirement for high concentrations of Ca2+ ions. Virions assembled in and shed from cells expressing the fusion protein contain very small amounts of intact viral RNA, as would be predicted for nuclease-mediated inhibition of viral multiplication.
Full text
PDF![364](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0688/42740/94617a2eb75b/pnas01480-0031.png)
![365](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0688/42740/1b2c4fa841e2/pnas01480-0032.png)
![366](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0688/42740/771cac15cf9b/pnas01480-0033.png)
![367](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0688/42740/6d2509c9ee43/pnas01480-0034.png)
![368](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0688/42740/7092d9eb8a19/pnas01480-0035.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bassin R. H., Tuttle N., Fischinger P. J. Rapid cell culture assay technic for murine leukaemia viruses. Nature. 1971 Feb 19;229(5286):564–566. doi: 10.1038/229564b0. [DOI] [PubMed] [Google Scholar]
- Bolognesi D. P., Montelaro R. C., Frank H., Schäfer W. Assembly of type C oncornaviruses: a model. Science. 1978 Jan 13;199(4325):183–186. doi: 10.1126/science.202022. [DOI] [PubMed] [Google Scholar]
- Feng Y. X., Yuan H., Rein A., Levin J. G. Bipartite signal for read-through suppression in murine leukemia virus mRNA: an eight-nucleotide purine-rich sequence immediately downstream of the gag termination codon followed by an RNA pseudoknot. J Virol. 1992 Aug;66(8):5127–5132. doi: 10.1128/jvi.66.8.5127-5132.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gabriel A., Boeke J. D. Reverse transcriptase encoded by a retrotransposon from the trypanosomatid Crithidia fasciculata. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9794–9798. doi: 10.1073/pnas.88.21.9794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goff S., Traktman P., Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol. 1981 Apr;38(1):239–248. doi: 10.1128/jvi.38.1.239-248.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greenhouse J. J., Petropoulos C. J., Crittenden L. B., Hughes S. H. Helper-independent retrovirus vectors with Rous-associated virus type O long terminal repeats. J Virol. 1988 Dec;62(12):4809–4812. doi: 10.1128/jvi.62.12.4809-4812.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hansen M., Jelinek L., Whiting S., Barklis E. Transport and assembly of gag proteins into Moloney murine leukemia virus. J Virol. 1990 Nov;64(11):5306–5316. doi: 10.1128/jvi.64.11.5306-5316.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes S. H., Greenhouse J. J., Petropoulos C. J., Sutrave P. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol. 1987 Oct;61(10):3004–3012. doi: 10.1128/jvi.61.10.3004-3012.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes S., Kosik E. Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors. Virology. 1984 Jul 15;136(1):89–99. doi: 10.1016/0042-6822(84)90250-2. [DOI] [PubMed] [Google Scholar]
- Mathias S. L., Scott A. F., Kazazian H. H., Jr, Boeke J. D., Gabriel A. Reverse transcriptase encoded by a human transposable element. Science. 1991 Dec 20;254(5039):1808–1810. doi: 10.1126/science.1722352. [DOI] [PubMed] [Google Scholar]
- Natsoulis G., Boeke J. D. New antiviral strategy using capsid-nuclease fusion proteins. Nature. 1991 Aug 15;352(6336):632–635. doi: 10.1038/352632a0. [DOI] [PubMed] [Google Scholar]
- Ott D. E., Keller J., Sill K., Rein A. Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences. J Virol. 1992 Oct;66(10):6107–6116. doi: 10.1128/jvi.66.10.6107-6116.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petropoulos C. J., Hughes S. H. Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells. J Virol. 1991 Jul;65(7):3728–3737. doi: 10.1128/jvi.65.7.3728-3737.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Versteegen R. J., Oroszlan S. Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses. J Virol. 1980 Mar;33(3):983–992. doi: 10.1128/jvi.33.3.983-992.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weldon R. A., Jr, Erdie C. R., Oliver M. G., Wills J. W. Incorporation of chimeric gag protein into retroviral particles. J Virol. 1990 Sep;64(9):4169–4179. doi: 10.1128/jvi.64.9.4169-4179.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wills J. W., Craven R. C. Form, function, and use of retroviral gag proteins. AIDS. 1991 Jun;5(6):639–654. doi: 10.1097/00002030-199106000-00002. [DOI] [PubMed] [Google Scholar]
- Wills N. M., Gesteland R. F., Atkins J. F. Evidence that a downstream pseudoknot is required for translational read-through of the Moloney murine leukemia virus gag stop codon. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):6991–6995. doi: 10.1073/pnas.88.16.6991. [DOI] [PMC free article] [PubMed] [Google Scholar]